Michael Piccolo Analyst PerformanceSVP, Equity Research, Special Situations at WedbushMichael Piccolo is a stock analyst at Wedbush across a range of sectors, covering 8 publicly traded companies. Over the past year, Michael Piccolo has issued 19 stock ratings, including buy and hold recommendations. While full access to Michael Piccolo's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Michael Piccolo's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings19 Last 0 YearsBuy Recommendations68.42% 13 Buy RatingsCompanies Covered8 Unique Companies Ratings Distribution19RatingsDistribution of strong buy, buy, hold, and sell ratings by Michael Piccolo.RatingPercentageCount Strong Buy0.0%0 ratings Buy68.4%13 ratings Hold31.6%6 ratings Sell0.0%0 ratingsOut of 19 total stock ratings issued by Michael Piccolo at Wedbush, the majority (68.4%) have been Buy recommendations, followed by 31.6% Hold.Best & Worst CallsThis analyst does not have any ratings with enough history to determine best and worst calls.Exchange CoverageExchangePercentageCountNYSE50.0% of companies on NYSE4 companiesNASDAQ50.0% of companies on NASDAQ4 companiesMichael Piccolo, an analyst at Wedbush, currently covers 8 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageRetail/Wholesale2 companies25.0%Medical2 companies25.0%Finance2 companies25.0%Business Services1 company12.5%Computer and Technology1 company12.5%Michael Piccolo of Wedbush specializes in stock coverage within the Retail/Wholesale sector, with additional focus on Medical and Finance companies.Coverage IndustriesIndustryPercentageINTERNET COMMERCE2 companies25.0%FIN - MISC SVCS2 companies25.0%MED/DENTAL - SUPP1 company12.5%MEDICAL SERVICES1 company12.5%STAFFING1 company12.5%IT SERVICES1 company12.5% Michael Piccolo's Ratings History at Wedbush Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsBBBYBed Bath & Beyond6/23/2026Boost Price Target$5.88$10.00Outperform$0.0000.00% ROITRIPTripAdvisor6/16/2026Boost Price Target$12.44$20.00Outperform$0.0000.00% ROITRIPTripAdvisor6/2/2026Initiated Coverage$12.10$19.00Outperform$0.0000.00% ROITRIPTripAdvisor6/2/2026Initiated Coverage$11.94$19.00Outperform$0.0000.00% ROISTAASTAAR Surgical5/29/2026Reiterated Rating$29.65$40.00Outperform$0.0000.00% ROISOLVSolventum5/15/2026Initiated Coverage$74.40$94.00Outperform$0.0000.00% ROISTAASTAAR Surgical5/14/2026Upgrade$29.40$40.00Outperform$0.0000.00% ROIBURBurford Capital5/11/2026Boost Price Target$5.16$5.00Neutral$0.0000.00% ROICCRNCross Country Healthcare5/7/2026Downgrade$13.05$13.25Hold$0.0000.00% ROITASKTaskUs5/7/2026Lower Price Target$6.37$12.00Outperform$0.0000.00% ROIRITMRithm Capital5/1/2026Lower Price Target$9.79$12.50Outperform$0.0000.00% ROITASKTaskUs4/15/2026Reiterated Rating$6.78$14.00Outperform$0.0000.00% ROISTAASTAAR Surgical4/9/2026Boost Price Target$20.88$26.00Neutral$0.0000.00% ROIBURBurford Capital3/30/2026Reiterated Rating$4.07$4.75Neutral$0.0000.00% ROIBURBurford Capital3/27/2026Lower Price Target$4.02$6.00Outperform$0.0000.00% ROICCRNCross Country Healthcare3/19/2026Upgrade$8.86$15.00Outperform$0.0000.00% ROITASKTaskUs2/3/2026Initiated Coverage$11.11$15.00Outperform$0.0000.00% ROICCRNCross Country Healthcare2/3/2026Initiated Coverage$9.23$11.00Neutral$0.0000.00% ROISTAASTAAR Surgical2/3/2026Initiated Coverage$18.04$26.00Neutral$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausDeutsche Bank Aktiengesellschaft Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
